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Abstract:  Breast cancer is the most common cancer and ovarian cancer is the 8th 
most common cancer affecting women worldwide. This study highlights the changes 
of trace element levels accompanied by the progression from ductal carcinoma in situ 
(DCIS) to invasive ductal carcinoma (IDC) of the breast, using micro probe 
Synchrotron Radiation X-ray Fluorescence (µSRXRF). The average values for the 
increase in Ca, Fe and Zn in tumour regions with respect to surrounding regions for 
the DCIS samples were significantly higher compared to the increase in the IDC 
samples (P <0.01).This study was also carried out to find a connection between 
ovarian cancer and breast cancer with respect to the cellular distribution of Ca, Cu, Fe, 
and Zn. For IDC, DCIS and ovarian cases, the statistical analysis reveals a significant 
increase in the levels of Ca, Cu and Zn concentrations in cancer tissue when compared 
to the normal surrounding tissue. For Fe, the differences between tumour regions with 
respect to surrounding regions were found to be not significant in IDC and ovarian 
cases. In DCIS cases, the results reveal a significant increase in the levels of Fe in 
cancer tissue when compared to the surrounding normal breast tissue (P <0.01). 
 
Introduction  
The most common type of breast cancer for women is mammary ductal carcinoma and it presents in 
two forms: invasive ductal carcinoma (IDC), an infiltrating, malignant and abnormal proliferation of 
neoplastic cells in the breast tissue; or ductal carcinoma in situ (DCIS), a noninvasive, potentially 
malignant cancer, where abnormal cells are restricted to the ducts. About 50% of untreated DCIS 
lesions are believed to rapidly transit to IDC, with a high degree of variability in this progression [1]. 
Our work to date has investigated the cellular distribution of Ca, Cu, Fe and Zn in IDC of breast tissue 
using micro probe Synchrotron Radiation X-ray Fluorescence (µSRXRF) [2-5]. These studies reveal 
an average increase for Ca, Cu and Zn levels in areas of malignancy. The levels of Fe on average 
showed an increase but in some samples there was a decrease in the tumour regions. The first part of 
the study reported here will focus on the investigation to determine whether the progression from 
DCIS to IDC is accompanied by changes of trace element levels. 
Ovarian cancer is the 8th most common cancer affecting women in the world [6]. Rosen DG et al. 
reported that ovarian cancer is responsible for 140,000 deaths around the world each year and has the 
lowest survival rate of all female cancers. Only 45% of patients are likely to survive after 5 years of 
diagnosis [7]. The most recent data regarding ovarian cancer reports that in 2008, there were 12.7 
million new cancer cases; 225,000 of which were ovarian cancer [6]. Ovarian cancer is often 
diagnosed as a secondary cancer alongside an initial primary cancer. Cases have been reported where 
ovarian cancer is diagnosed in addition to breast cancer and it has been found that women inflicted 
with breast cancer or with family history of breast cancer are also at an increased risk of developing  
ovarian cancer. Consequently with ovarian cancer being so closely linked to breast cancer, the second 
part of the study reported here was carried out to find a connection between ovarian cancer and breast 
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cancer with respect to the cellular distribution of Ca, Cu, Fe, and Zn using µSRXRF. Finding a 
connection between the two diseases may provide insight with regards to many unknown factors of the 
two diseases as it has been found that breast and ovarian cancer tissues have similar properties, and 
thus the same biomarkers are able to be used to diagnose and monitor the disease progression in both 
cancers [8]. Utilising in vivo experiments and the use of chelators in mice, Merlot, et al. found that a 
slight decrease in Fe levels could be observed in the cancer cells [9]. It was also found that Cu levels 
typically tend to be elevated in both breast and ovarian cancer tissues. This trend is seen in different 
age groups and geographical locations of those inflicted with the diseases. The levels of Zn were also 
investigated and found to remain constant. 
Samples: 
The IDC, DCIS and ovarian samples were obtained from the Cancer Research UK Tumour Pathology 
Group, Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford.  
All samples were Formalin Fixed Paraffin Embedded (FFPE) tissues arranged as micro arrays of 1.0 
mm diameter and 10μm thickness. For each tissue micro array (TMA), two slices were cut from the 
paraffin block, one being 10 μm thick, the other being 5 μm thick and cut adjacent to the 10 μm slice. 
The 5 μm thick slice was mounted on a standard glass slide and then stained using Hematoxylin and 
Eosin stain (H&E) staining. The H&E slide was then optically imaged to produce high resolution 
images which clearly identify tumour regions in the samples and can be used as a reference slide for 
the elemental distribution maps produced from the experimental slide. The 10 μm thick slide was 
mounted on 4 μm Ultralene XRF film that was stretched and held in a bespoke frame. 
Method:  
The IDC, DCIS and ovarian sample measurements were carried out using the Synchrotron Radiation 
X-ray Fluorescence (SRXRF) at beamline I18, DIAMOND, UK and FLUO beamline at ANKA, 
Karlsruhe, Germany. Figure 1 shows the sample micro-array slide and a schematic of the experimental 
set-up. Figure 1 also shows the 90º geometry between the incident beam and the detector, which is 
maintained to utilise the strong polarization of the synchrotron photon beam. This arrangement 
provides significant suppression of the scattered incident photons in the plane of the electron orbit, 
while the fluorescence signal which is required for the measurement remains unaffected. The sample 
position is set at 45º to the incident photon beam.  The experimental set up took on a similar form at 
the two facilities with specific details at each Beamline as given in table 1. The data collected at each 
point in the scan is in the form of an elemental spectrum that is collected using a Si (Li) detector 
(Oxford Instruments) at the FLUO beamline and a 4-element Vortex SDD detector at beamline I18. 
These spectra were analysed using AXIL and PyMCA programs respectively both of which are 
designed to fit the XRF peaks, remove the background and separate the overlapping peaks. The final 
metal distribution for each metal is composed by the element’s peak intensity in each sample position. 
Maps of the Zn, Fe, Cu and Ca distributions were produced using IDL v6.3 (ITT Virtual Information 
Software). This program enabled regions of interest to be set on the maps encompassing tumour cell 
regions and regions of surrounding non-tumour tissue which is useful for further statistical analysis. 
Statistics obtained from these regions including mean pixel value and the standard error of the means. 
The parameter compared is the mean of Ca, Fe, Cu and Ca levels in tumour (T) and normal (N) 
regions. When comparing the changes of trace element levels between IDC and DCIS cases, the 
parameter compared is the average value for the percentage difference in the metal levels in tumour 
regions with respect to surrounding normal regions for each case (i.e for each element ((Tumour 
content-Normal content)/Normal content)*100%. The Shapiro–Wilk test was used for each element in 
each category to test if the data set was consistent with a Gaussian distribution function. For IDC, 
DCIS and ovarian tumour and normal data, Wilcoxon Rank test was used for comparing the difference 
in Ca, Fe, Cu and Zn levels for non normally distributed related data, while paired t-test was used for 
normally distributed related data. For comparing the percentage difference in Ca, Fe, Cu and Zn levels 
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in IDC samples with respect to DCIS samples, P values from Mann Whitney U and Independent t test 
were obtained.  
 
Figure 1:  Schematic diagram showing samples arranged as a tissue micro array and mounted on a sample holder 
held on an xyz translator stage.  The sample array is positioned at 45° to the synchrotron beam.  
 
Beam line FLUO at ANKA I18 at DIAMOND 
Incident Energy 10.1  keV    11 keV 
Beam Size 5 m x 15 m 5 µm x 5 µm 






Fitting software AXIL program PyMCA program 
Final parameter 
compared  
Total metal Kα 
counts 
Total metal Kα counts 
normalised to the 
incident scatter peak 
area 
 
Table 1:  µSRXRF beamlines experimental set up details. 
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Result and Discussion:  
1- Elemental Mapping : 
DCIS, IDC and ovarian carcinoma samples were scanned using a µSRXRF technique. Figure 2 shows 
an example of the elemental distributions maps of Zn, Fe, Cu, and Ca in two samples of DCIS tissue, 
two samples of IDC tissue and two ovarian tissue samples. The dark areas of the H&E stained 
reference image show the tumour areas, and the lighter regions are the normal tissue. Correlations 
were found between the stained reference images and the elemental distributions indicating an 
increase in element concentrations in most of the tumour regions of the sample (darker coloured areas 
correspond to higher metal content), but it can also be seen that the elemental distribution of Fe in 




Figure 2: Examples of sample maps, showing the reference H&E stained reference image with the 
corresponding Ca, Zn, Cu and Fe distribution maps. Examples are shown of DCIS, IDC and ovarian 
carcinoma. 
 
22nd International Congress on X-Ray Optics and Microanalysis IOP Publishing
Journal of Physics: Conference Series 499 (2014) 012014 doi:10.1088/1742-6596/499/1/012014
4
 
2- Elemental concentration in IDC and DCIS samples: 
The relative levels of Zn, Cu, Fe and Ca were estimated in 20 IDC and 20 DCIS FFPE samples and 
normal surrounding breast tissue. Table 2 shows a summary of the descriptive statistical parameters 
including the mean, the standard error of the means  and the P values for comparing the difference in 
Ca, Fe, Cu and Zn levels in tumour regions (T) with respect to surrounding normal regions (N) for 











IDC-Ca-T 2144.73 420.78 
<0.01* 
IDC-Ca-N 1083.15 208.05 
IDC-Fe-T 140.61 33.45 
0.84 
IDC-Fe-N 129.60 26.14 
IDC-Cu-T 51.07 17.41 
<0.01* 
IDC-Cu-N 38.06 11.97 
IDC-Zn-T 282.84 75.62 
<0.01* 
IDC-Zn-N 109.83 22.79 
DCIS-Ca-T 3223.68 180.55 
<0.01* 
DCIS-Ca-N 1050.95 79.48 
DCIS-Fe-T 96.30 10.57 
<0.01* 
DCIS-Fe-N 38.12 4.98 
DCIS-Cu-T 80.70 7.95 
<0.01* 
DCIS-Cu-N 57.76 5.00 
DCIS-Zn-T 201.75 12.61 
<0.01* 
DCIS-Zn-N 41.39 2.81 
 
Table 2:  Statistical summary of the mean and the standard error of the means of Ca, Fe, Cu and Ca levels in 
tumour (T) regions with respect to the normal (N) regions in DCIS and IDC sample. The corresponding P 
values from Wilcoxon Rank test (2-tailed).*Significantly different at P <0.01.  
The statistical analysis reveals an average increase in the levels of Ca, Cu and Zn in IDC tissue when 
compared to the normal surrounding breast tissue (P <0.01).  For Fe, the differences between tumour 
regions with respect to surrounding regions were found to be not significant in IDC cases (P =0.84).   
In DCIS cases, the results reveal a significant increase in the levels of Ca, Fe, Cu and Zn levels in 
DCIS tissue when compared to the surrounding normal breast tissue(P <0.01). Table 3 shows a 
summary of the descriptive statistical parameters including the percentage difference of the mean 
levels in tumour regions with respect to surrounding normal regions for IDC and DCIS samples (i.e 
for each element ((Tumour content-Normal content)/Normal content)*100%, the standard error of the 
percentage difference of the means, and the P values for comparing the percentage difference in Ca, 
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Groups 
% Difference of 













DCIS-Ca 229.80 24.91 




DCIS-Fe 178.32 37.61 




DCIS-Cu 40.96 6.31 




DCIS-Zn 419.65 44.44 
 
Table 3:  Statistical summary of the percentage difference of Ca, Fe, Cu and Ca levels in tumour regions 
with respect to the normal regions for IDC and DCIS samples, the standard error of the percentage 
difference of the means, and the P values for comparing the percentage difference in the mean metal  levels 





(2-tailed). *Significantly different at P <0.01. 
The null hypothesis in this part of the study is that: the percentage differences in the metal levels in the 
two groups of cancer (IDC and DCIS) are equal. The null hypothesis is rejected when the p-value is 
less than 0.05. This test will enable us to assess if the progression from DCIS to IDC of the breast is 
accompanied by significant metal changes. The average values for the percentage increase in Ca, Fe 
and Zn in tumour regions with respect to surrounding regions for the DCIS samples were significantly 
higher compared to the percentage increase in the IDC samples (P <0.01). The percentage difference 
between tumour and normal regions of Cu is not significantly higher in DCIS cases compared to the 
IDC cases. The results presented in our most recent publication [5] that combined data from 128 
formalin fixed paraffin embedded IDC samples indicate the importance of correlating the changes in 
elemental levels to the clinical prognostic factors such as oestrogen receptor (ER) status. In order to 
take this into account the DCIS and IDC samples were classified on the basis of their ER status. Table 
4 shows a summary of the results including only the ER +ve group DCIS and IDC sample. The clinical 















IDC-Ca 114 18 
0.14 
DCIS-Ca 203 72 
IDC-Fe -9 11 
0.033* 
DCIS-Fe 268 119 
IDC-Cu 30 8 
0.36 
DCIS-Cu 56 26 
IDC-Zn 166 43 
0.04* 
DCIS-Zn 337 77 
 
Table 4: Statistical summary of the percentage difference of Ca, Fe, Cu and Ca levels in tumour regions with 
respect to the normal regions for IDC and DCIS ER +ve samples, the standard error of the percentage difference 
of the means, and the P values for comparing the percentage difference in the mean metal levels in IDC samples 
with respect DCIS samples. The corresponding P values from Independent t test (2-tailed). *Significantly 
different at P <0.05. 
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For the ER +ve DCIS and IDC samples, the statistical analysis reveals that the percentage difference 
in Fe and Zn in tumour regions with respect to surrounding regions for the DCIS samples were 
significantly higher compared to the percentage in the IDC samples.  
3- Elemental concentration in ovarian cancer samples: 
This part of the study examined the cellular distribution of the trace of the same four elements in 20 
FFPE ovarian cancer samples and normal surrounding ovarian tissue. Table 5 shows a summary of the 
descriptive statistical parameters including the mean values and the P values for of the comparisons. 
Groups 

















Ca-N 0.011694 0.00105 




Fe-N 0.004053 0.00017 




Cu-N 0.000614 0.00002 
Zn-T 0.006005 0.00038 
<0.012* 
Zn-N 0.003191 0.00021 
 
Table 5: Statistical summary of the mean and the standard error of the means of Ca, Fe, Cu and Ca levels in 
tumour (T) regions and the normal (N) regions of the ovarian samples. The corresponding P values from 
paired T test
1 
(2-tailed) or Wilcoxon test
2 
(2-tailed).*Significantly different at P <0.01. 
 
The null hypothesis in this part of the study is that: the trace element levels in tumour and normal 
ovarian tissues are equal. When the p-value is less than 0.05, the null hypothesis is rejected. The 
statistical analysis reveals a significant increase in the levels of Ca, Cu and Zn concentrations in 
ovarian cancer tissue when compared to the normal surrounding ovarian tissue. For Fe, the differences 
in between tumour regions with respect to surrounding regions were found to be not significant. 
Conclusion:  
 
In the first part of the study, the analysis reveals a significantly higher percentage difference in Ca, Fe 
and Zn in tumour regions with respect to surrounding regions for the DCIS samples compared to the 
percentage difference in the IDC samples. When the samples were reclassified in terms of their ER 
+ve status the statistically significant differences between the two types of breast tumour are again 
observed for Fe and Zn. The Fe result is in agreement with our previous study [5] which showed that 
imbalance in Fe concentration (deficiency) should be viewed as an important risk factor that is 
associated with aggressive features of the cancer.  The second part of the study shows that the trend of 
the differences in the levels of Ca, Fe, Cu and Zn elements is similar between the IDC and ovarian 
cancers. For IDC and ovarian cases, the statistical analysis reveals a significant increase in the levels 
of Ca, Cu and Zn concentrations in cancer tissue when compared to the normal surrounding tissue. For 
Fe, the differences between tumour regions with respect to surrounding regions were found to be not 
significant in IDC and ovarian cases. This research will serve as a base for future studies aimed at 
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